Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Fish and Richardson
Deloitte
Healthtrust
US Army
Medtronic
Farmers Insurance
Julphar
Dow

Generated: October 19, 2018

DrugPatentWatch Database Preview

Epi Hlth Company Profile

« Back to Dashboard

What is the competitive landscape for EPI HLTH, and what generic alternatives to EPI HLTH drugs are available?

EPI HLTH has two approved drugs.

There are three US patents protecting EPI HLTH drugs.

Summary for Epi Hlth
US Patents:3
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Epi Hlth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epi Hlth SITAVIG acyclovir TABLET;BUCCAL 203791-001 Apr 12, 2013 RX Yes Yes 8,747,896 ➤ Sign Up Y ➤ Sign Up
Epi Hlth SITAVIG acyclovir TABLET;BUCCAL 203791-001 Apr 12, 2013 RX Yes Yes 8,592,434 ➤ Sign Up Y ➤ Sign Up
Epi Hlth SITAVIG acyclovir TABLET;BUCCAL 203791-001 Apr 12, 2013 RX Yes Yes 8,791,127 ➤ Sign Up Y ➤ Sign Up
Epi Hlth MINOLIRA minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 209269-002 May 8, 2017 RX No No ➤ Sign Up ➤ Sign Up
Epi Hlth MINOLIRA minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 209269-001 May 8, 2017 RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Epi Hlth Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB10/012 United Kingdom ➤ Sign Up PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
C0038 France ➤ Sign Up PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Harvard Business School
Dow
Cipla
Medtronic
Argus Health
McKinsey
Fuji
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.